“Beyond Glucose: Empagliflozin’s Impact on Fatty Liver in Patients with Type 2 Diabetes; A True Game Changer” (2025) Indus Journal of Bioscience Research, 3(2), pp. 193–198. doi:10.70749/ijbr.v3i2.663.